2019
DOI: 10.1039/c8bm01556b
|View full text |Cite
|
Sign up to set email alerts
|

Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells

Abstract: Interleukin-2 (IL-2) is a potent T-cell mitogen that can adjuvant anti-cancer adoptive T-cell transfer (ACT) immunotherapy by promoting T-cell engraftment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
42
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 67 publications
(42 citation statements)
references
References 34 publications
(45 reference statements)
0
42
0
Order By: Relevance
“…[ 25 ] Covalent conjugation has been investigated as a better alternative to noncovalent binding, and has found application in reducing the immune response after transplants in vivo, [ 45–47 ] as well as in cancer therapy by directly targeting T cells and boosting the immune response toward tumors. [ 94–96 ] However, the lack of selectivity of covalent approaches that use functional groups already present at the plasma membrane, such as amines and thiols, limits their applications in targeted cell therapies and increases their side effects. On the other hand, bio‐orthogonal chemistries offer unique and highly biocompatible routes to explore mammalian cell surface engineering.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 25 ] Covalent conjugation has been investigated as a better alternative to noncovalent binding, and has found application in reducing the immune response after transplants in vivo, [ 45–47 ] as well as in cancer therapy by directly targeting T cells and boosting the immune response toward tumors. [ 94–96 ] However, the lack of selectivity of covalent approaches that use functional groups already present at the plasma membrane, such as amines and thiols, limits their applications in targeted cell therapies and increases their side effects. On the other hand, bio‐orthogonal chemistries offer unique and highly biocompatible routes to explore mammalian cell surface engineering.…”
Section: Discussionmentioning
confidence: 99%
“…[ 95 ] This approach was then extended to the delivery of IL‐2 in vivo, improving the efficacy of this therapy against melanoma metastases. [ 96 ]…”
Section: Targeting Polymeric Nanoparticles At the Cell Surfacementioning
confidence: 99%
“…In order to reduce the severity of adverse effects, Xie Y.Q. et al (2019) developed a complex delivery system, binding redox-responsive IL-2/Fc nanogels to the surface of adoptively transferred T cells [34]. Interestingly, the cytokine nanogels are able to selectively release IL-2 in response to the activation of T cell receptors after antigen recognition in tumors [34].…”
Section: High-dose Interleukin-2 (Il-2)mentioning
confidence: 99%
“…et al (2019) developed a complex delivery system, binding redox-responsive IL-2/Fc nanogels to the surface of adoptively transferred T cells [34]. Interestingly, the cytokine nanogels are able to selectively release IL-2 in response to the activation of T cell receptors after antigen recognition in tumors [34]. In a melanoma mouse model the delivery system showed improved efficiency, without obvious toxicity [34].…”
Section: High-dose Interleukin-2 (Il-2)mentioning
confidence: 99%
See 1 more Smart Citation